The 3 analysts offering 12-month price forecasts for Heat Biologics Inc have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 20.00. The median estimate represents a +408.72% increase from the last price of 6.88.
The current consensus among 3 polled investment analysts is to Buy stock in Heat Biologics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.31
Reporting Date Mar 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.